Under physiological conditions, interaction between ceftriaxone and human serum albumin was investigated by using fluorescence spectroscopy and ultra violet (UV) absorption spectrum. From spectral analysis, ceftriaxone showed a strong ability to quench the intrinsic fluorescence of human serum albumin (HSA) through a static quenching procedure. The binding constant (k) is estimated as K=1.02× 10 3 M -1 at 298 K. Fourier transform infrared spectroscopy (FT-IR) spectroscopy with Fourier self-deconvolution technique was used to determine the protein secondary structure and drug binding mechanisms. The observed spectral changes indicated the formation of H-bonding between ceftriaxone and HSA molecules at higher percentage for -helix than for the -sheets.
INTRODUCTION
In recent years, many investigations on the binding of drugs and natural products to human serum albumin (HSA) were carried out (Il'ichev et al., 2002; Qing et al., 2011; Ahmad et al., 2006; Liu et al., 2009 ). Ceftriaxone, as a possible ligand, was not studied in details upon its binding reaction with HSA. It has been reported that Ceftriaxone binds to HSA (Guowen et al., 2011 , Bibiana et al., 1996 .
Ceftriaxone, a cephalosporin, is bound reversibly to defatted human serum albumin from adults, with a first stoichiometric binding constant of 6x10 4 M -1 , as found by equilibrium dialysis at pH 7.4, 37C (Roberton et al., 1989) . So far, none of the investigations determine in details the Ceftriaxone-HSA binding constant and the effects of Ceftriaxone complexation on the protein.
Ceftriaxone belongs to a group of antibiotics called the cephalosporins. It is a parenteral cephalosporin that displays a broad spectrum of activity against Gram-negative and Gram-positive pathogens; its chemical structure is shown in Figure 1 (Bilirubin et al., 1989) . Ceftriaxone is indicated for a wide variety of infections. These include infections of the lower respiratory and urinary tracts, bacterial septicemia, skin and skin structure infections, bone and joint infections, pelvic inflammatory disease, uncomplicated gonorrhea, intra-abdominal infections, acute bacterial otitis media, meningitis, as well as surgical prophylaxis (Quaglia et al., 1997) .
The drug is widely used because of its broad spectrum of antibacterial activity, infrequent side-effects, and long serum half-life and it has recently been recommended as the drug of choice for use in newborn infants exposed to Neisseria gonorrhea during delivery (Bibiana et al., 1996) .
It has been reported that ceftriaxone is transported through the blood-brain barrier (Scott et al., 2008; Reynold et al., 1987) and it is widely accepted that some conformational diseases, such as Alzheimer's and prion diseases can be the result of misfolding due to lack of stability in parallel β-sheets (Locht et al., 1990) . Recent reports suggest that somedrugs may accelerate these *Corresponding author. E-mail: abuteir@science.alquds.edu. neurodegenerative diseases (Rabia et al., 2009 ). This emphasizes the needs to understand protein folding and sheets stability in some proteins complexes with drugs.
The widespread use of ceftriaxone and its transport through the blood-brain barrier makes it necessary to study structural changes of ceftriaxone -protein complexes to understand the biological effects and functions of ceftriaxone in the body. Thus, the study of ceftriaxoneprotein interaction is of great interest in the field of biophysics, life sciences and clinical medicine.
HSA is the most abundant protein in human plasma, which is synthesized in the liver (Fengling et al., 2006) and is able to bind and thereby transport various compounds such as fatty acids, hormones, bilirubin, tryptophan, steroids, metal ions, therapeutic agents and a large number of drugs. HSA serves as the major soluble protein constituent of the circularity system, it contributes to colloid osmotic blood pressure, it can bind and carry drugs which are mainly poorly soluble in water . HSA accounts for approximately 60% of the total plasma protein corresponding to a concentration of 40 mg/ml in the blood (~0.6 mM) . The three dimensional structure of HSA was determined through x-ray crystallographic measurements (He et al., 1992) . This globular protein consists of a single polypeptide chain of 585 amino acids (Hal et al., 2000) , which have a molecular weight of 66 kDa (Bian et al., 2004) . HSA composed of three homologous domains I, II and III, each containing two sub-domains, A and B, each having six and four α-helices, respectively (Curry et al., 1999) . The tertiary structure of HSA is stabilized by 17 disulphide bridges giving it a heart shaped molecule (He et al., 1992; Bian et al., 2004) .
It has been shown that distribution, free concentration, and metabolism of various drugs can be significantly altered as a result of their binding to HSA (Artali et.al, 2005; . The binding properties of albumin depend on the three dimensional structure of the binding sites, which are distributed all over the molecule.
Strong binding can decrease the concentrations of free drugs in plasma, whereas weak binding can lead to a short lifetime or poor distribution or both. Its remarkable capacity to bind a variety of drugs results in its prevailing role in drug pharmacokinetics and pharmacodynamics (Kandagal et.al, 2007) .
Multiple drug binding sites have been reported for HSA by several groups of researchers (Bhattacharyya et al, 2006; Simard et al., 2006; Ulrich .et al., 2006) . The principal regions of ligand binding sites of HSA are located in hydrophobic cavities in sub domains IIA and IIIA, which corresponds to site I and site II, respectively. Site I is dominated by strong hydrophobic interaction with most neutral, bulky, heterocyclic compounds, while site II mainly by dipole-dipole, van der Waals, and/or hydrogenbonding interactions with many aromatic carbo-xylic acids. HSA contained a single tryptophan residue in domain IIA and its intrinsic fluorescence is sensitive to the ligands bound nearby (Krishnakumar et al., 2002; Muravchick et al., 1995) . Therefore, it is often used as a probe to investigate the binding properties of drugs with HSA.
The interaction of ceftriaxone sodium (CS), a cephalosporin antibiotic, with the major transport protein, bovine serum albumin (BSA), was investigated using different spectroscopic techniques such as fluorescence, circular dichroism (CD), and UV-vis spectroscopy (Cao et al., 2012) . The mechanism of the interaction between bovine serum albumin (BSA) and ceftriaxone with and without zinc (II) (Zn 2+ ) was studied employing fluorescence, ultraviolet (UV) absorption, circular dichroism (CD), and synchronous fluorescence spectral methods. The intrinsic fluorescence of BSA was quenched by ceftriaxone in a static quenching mode, which was authenticated by Stern-Volmer calculations.
The binding constant, the number of binding sites, and the thermodynamic parameters were obtained, which indicated a spontaneous and hydrophobic interaction between BSA and ceftriaxone regardless of Zn 2+ (Liu et al., 2012) . In this study, we have investigated the interaction of ceftriaxone with HSA by means of FT-IR, UV/VIS, and fluorescence spectrophotometer. Infrared spectroscopy provides measurements of molecular vibrations due to the specific absorption of infrared radiation by chemical bonds. It is known that the form and frequency of the Amide I band, which is assigned to the C=O stretch-ing vibration within the peptide bonds is very characteristic for the structure of the studied protein.
From the band secondary structure, components peaks (α-helix, β-strand) can be derived and the analysis of this single band allows elucidation of conformational changes with high sensitivity (Abu et al., 2011) . This work will be limited to the mid-range infrared, which covers the frequency range from 4000 to 400 cm -1 . This wavelength region includes bands that arise from three conformational sensitive vibrations within the peptide backbone (Amides I, II and III) of these vibrations. Amide I is the most widely used and can provide information on secondary structure composition and structural stability (Cui et al., 2008; Rondeau et al., 2007) .
One of the advantages of infrared spectroscopy is that it can be used with proteins that are either in solution or in thin film. In addition there is a growing body of literature on the use of infrared to follow reaction kinetics and ligand binding in proteins, as will as a number of infrared studies on protein dynamics.
The identification of the binding sites in albumin was also performed using probes for the so-called sites I, II, bilirubin and fatty acids binding sites. Albumin showed two types of binding sites for cefoperazone and ceftriaxone, while for cefsulodin it showed a single type of binding site (Pico et al., 1996) .
The mechanism of the interaction between human serum albumin (HSA) and ceftriaxone has been studied by using UV, fluorescence and FTIR spectroscopy. Furthermore temperature dependent conformation of HSA structure at different concentrations of Ceftriaxone has been studied by FT-IR spectroscopy.
MATERIALS AND METHODS
Human serum albumin (HSA, 96-99% purity) and Ceftriaxone disodium salt hemi(heptahydrate) in powder form were purchased from Sigma Aldrich chemical company and used without further purification.
Preparation of stock solutions
HSA was dissolved in phosphate buffer saline, at physiological pH 7.4 at (80 mg/ml) concentration. Ceftriaxone with molecular weight of 66.5 kDa was dissolved in phosphate buffer saline (1.21 mg/ml), the solution was placed in ultrasonic water path (SIBATA AU-3T) for 6 h to ensure that all the amount of Ceftriaxone was completely dissolved. The final concentrations of HSA-Ceftriaxone complexes were prepared by mixing equal volume of HSA and Ceftriaxone stock solution. HSA concentration in all samples were Abu Teir et al. 3 fixed at 40 mg/ml (~0.6 mM). However, the concentration of Ceftriaxone in the final protein drug solutions was decreased gradually to attain the desired drug concentrations of 0.687, 0.910, 1.14, 1.37, 1.60, 1.83 and 2.06 mM. The solution of Ceftriaxone and HSA were incubated for 1 h (at 25C) before spectro-scopic measurements were taken.
Fluorescence
The fluorescence measurements were performed by a Nano-Drop ND-3300 Fluorospectrometer at 25C. The excitation had been done at the wavelength of 360 nm and the maximum emission wavelength was at 439 nm. The excitation source comes from one of three solid-state light emitting diodes (LED's). The excitation source options include: UV LED with maximum excitation of 365 nm, Blue LED with excitation of 470 nm, and white LED from 500 to 650 nm excitation. A 2048-element CCD array detector covering 400-750 nm, was connected by an optical fiber to the optical measurement surface. The emission spectra were recorded for free HSA 40 mg/ml (~0.6 mM) and for its complexes with ceftriaxone solutions with the concentrations of (0.687, 0.910, 1.14, 1.37, 1.60, 1.83, 2.06 mM). Repeated measurements were done for all samples and no significant differences were observed.
FT-IR spectroscopy experimental procedures
The FT-IR measurements were obtained on a Bruker IFS 66/S spectrophotometer equipped with a liquid nitrogen-cooled MCT detector and a KBr beam splitter. The spectrometer was continuously purged with dry air during the measurements. The absorption spectra were obtained in the wave number range of 400-4000 cm -1 . A spectrum was taken as an average of 60 scans to increase the signal to noise ratio, and the spectral resolution was at 4 cm -1 . The aperture used in this study was 8 mm, since we found that this aperture gives best signal to noise ratio. Baseline correction, normalization and peak areas calculations were performed for all the spectra by OPUS software. The peak positions were determined using the second derivative of the spectra. The infrared spectra of HSA, and Ceftriaxone-HSA complex were obtained in the region of 1000-1800 cm−1. The FT-IR spectrum of free HSA was acquired by subtracting the absorption spectrum of the buffer solution from the spectrum of the protein solution. For the net interaction effect, the difference spectra [(protein and Ceftriaxone solution) -(protein solution)] were generated using the featureless region of the protein solution 1800-2200 cm -1 as an internal standard (Surewicz et al., 1993) . The accuracy of this subtraction method is tested using several control samples with the same protein or drug concentrations, which resulted into a flat base line formation. The obtained spectral differences were used here, to investigate the nature of the drug-HSA interaction. We had also used ELAB 12/05 thermo system to directly and simultaneously determine the thermo-dependent structural changes of drug-protein complexes.
RESULTS AND DISCUSSION

Analysis of fluorescence quenching of HSA by Ceftriaxone
Fluorescence spectroscopy is one of the most widely used spectroscopic techniques in the fields of biochemistry and molecular biophysics today (Royer et al., 1995). Fluorescence measurements can give some information on the binding mechanism of small molecule substances to protein, including binding mode, binding constants, binding sites and intermolecular distances . The fluorescence of HSA comes from tryptophan, tyrosine and phenylalanine residues. Actually, the intrinsic fluorescence of HSA is almost contributed by tryptophan alone (Sulkowska et al., 2002) . Figure 2 shows the fluorescence spectra of HSA in the presence of various concentrations of ceftriaxone. It is obvious that HSA fluorescence intensity gradually decreased with the increase of Ceftriaxone concentration, while the peak position shows little or no change upon increasing the concentration of Ceftriaxone to HSA, indicating that Ceftriaxone binds to HSA. Under the same condition, no fluorescence of Ceftriaxone was observed hich indicates that Ceftriaxone could quench the auto fluorescence of HSA which confirm that Ceftriaxone interacts with HSA, leading to a change in the microenvironment around the tryptophan residue exposing it to the polar solvent Cui et al., 2007) .
Two mechanisms, namely dynamic quenching and static quenching are responsible for the fluorescence quenching. The possible quenching mechanism can be deduced from the Stern-Volmer plot. The dynamic quenching process can be described by the Stern-Volmer equation (Tian et al., 2003) (1) Where, F 0 and F are the fluorescence intensities of HSA in the absence and presence of the quencher, respectively. Kq is the quenching rate constant of the biomolecule, K SV is the Stern-Volmer dynamic quenching constant, and K SV =K q τ 0 . τ 0 is the average lifetime of the biomolecule without quencher. The value of τ 0 of the biopolymer was 10 -8 s -1 (Chen et al., 1990) ) for ceftriaxone-HSA complexes. Generally, the maximum dynamic quenching constant, Kq of various kinds of quenchers with biopolymer was 2.0×10 10 L mol -1 s -1 (Lakowicz et al., 1973) .
Obviously, the values of kq were greater than that of the maximum dynamic quenching constant. This suggested that the fluorescence quenching was not the result of dynamic quenching, but the consequence of static quenching (Chen et al., 1990 , Wang et al., 2008 .
When static quenching is dominant, the modified SternVolmer equation could be used (Lakowicz, et al.1999) . (2) Where, K is the binding constant of ceftriaxone with HSA, and can be calculated by plotting 1/(F0-F) vs. 1/L ( Figure  4 ). The value of K was obtained from the values of slope and intercept, respectively. K equals the ratio of the intercept to the slope.
The value of K was 1.02×10 3 M -1 at room temperature, which is consistent with the value obtained by Bibiana et al., (1996) and Patrick et al. (1990) . In vitro protein binding studies were conducted to examine the interaction between ceftriaxone (CEF), probenecid (PROB) and diazepam (DIAZ). The presence of PROB and DIAZ at concentrations equal to molar albumin concentration caused a decrease in CEF affinity from 3.7 x 10 4 M -1 (control) to 1.1 x 10 4 (PROB) and 2.6 x 10
, but not in binding capacity in pooled human plasma .
The value obtained is indicative of a weak Ceftriaxone-HSA interaction with respect to the other drug-HSA complexes with binding constants in the range of 10 5 and 10 6 M -1 (Kragh-Hansen et al., 1981) . The highly effective quenching constant in this case has lead to a lower value of binding constant between the drug and HSA due to an effective hydrogen bonding between ceftriaxone and HSA.
FT-IR spectroscopy
FT-IR spectroscopy is a powerful technique for the study of hydrogen bonding (Li et al., 2006) , and has been identified as one of the few techniques that is established in the determination of protein secondary structure at different physiological systems (Sirotkin et al., 2001; Arrondo et al., 1993) . The information on the secondary structure of proteins could be deduced from the infrared spectra. Proteins exhibit a number of amide bands, which represent different vibrations of the peptide moiety. The amide group of proteins and polypeptides presents characteristic vibrational modes (amide modes) that are sensitive to the protein conformation and largely been constrained to group frequency interpretations (Ganim et al., 2006) .
The modes most widely used in protein structural studies are amide I, amide II and amide III. Amide I band ranging from 1700 to 1600 cm -1 and arises principally from the C=O stretching (Vandenbussche G et al., 1992) , has been widely accepted to be used (Workman et al., 1998) . The amide II band is primarily N-H bending with a contribution from C-N stretching vibrations; amide II ranging from 1600 to 1480 cm -1 while amide III band ranging from 1330 to 1220 cm -1 which is due to the C-N stretching mode coupled to the in-plane N -H bending mode (Arrondo et al., 1993; Jackson et al., 1991) .
The second derivative of free HSA is shown in Figure  5A , where the spectra is dominated by absorbance bands of amide I and amide II at peak positions 1656 and 154 4cm -1 , respectively. Figure 5B , shows the spectrum of ceftriaxone-HSA complexes with different concentrations of ceftriaxone.
The peak positions of amide I bands in HSA infrared spectrum shifted as listed in . In addition, a new peaks at 1552 and 1568 cm -1 appeared after the interaction of ceftriaxone with HSA. In the Amide III region little or no change of the peak positions has been observed. The changes of these peak positions and peak shapes implied that the secondary structures of HSA had been changed by the interaction of ceftriaxone with HSA. The minor changes in peak positions can be attributed to the effect of the newly formal H-bonding between ceftriaxone molecules with the protein. It is suggested that, the shift to a higher frequency for the major peak in amide I region (1656-1658 cm -1 ) came as a result of stabilization by hydrogen bonding by having the C-N bond assuming partial double bond character due to a low of electrons from the C=O to the C-N bond (Jackson et al., 1991) . Determination of the secondary structure of HSA and its ceftriaxone complexes was carried out on the basis of the procedure described by Byler et al. (1986) . In this work, a quantitative analysis of the protein secondary structure for the free HSA and ceftriaxone-HSA complexes in dehydrated films is determined from the shape of amides I, II and III bands. Infrared Fourier self-deconvolution with second derivative resolution and curve fitting procedures, were applied to increase spectral resolution and therefore to estimate the number, position and area of each component bands. The procedure was in general carried out considering only components detected by second derivatives and the half widths at half height (HWHH) for the component peaks are kept around 5 cm -1
; the above procedure was reported in our recent publications (Abu et al., 2011; Darwish et al., 2010; Abu et al., 2012) .
The component bands of amides I, II, and III regions were assigned to a secondary structure accor-ding to the frequency of its maximum raised after Fourier self deconvolution have been applied for amide I band ranging from 1610 to 1700 cm -1 generally assigned as follows: 1610-1627 cm Amide I band assuming higher sensitivity to the change of protein secondary structure (Vass et al., 1997) . However, it has been reported that amide II and amide III bands have high information content and could be used for prediction of proteins secondary structure (Oberg et al., 2004 .
Based on the above assignments, the percentages of each secondary structure of HSA were calculated from the integrated areas of the component bands in amide I, amide II and amid III, respectively. Table 2 shows the content of each secondary structure of HSA before and after the interaction with ceftriaxone at different concentrations. The percentage values for the components of amide I of free HSA are consistent with the results of other recent spectroscopic studies. Figure 6 illustrates the variation of relative intensities with concentration change for the α-helix, parallel and antiparallel -sheets in HSA free and ceftriaxone-HSA complexes. The results exhibited a reduction of α-helical structures so that of amide II and amide III showed similar trends in their percentage values to that of amide I.
The decrease of α-helix percentage with the increase of ceftriaxone concentrations is evident in the calculations and this trend is consistent in the three Amide regions. However, for the parallel and antiparallel β-sheet, relative percentage increased with increasing ceftriaxone concentrations and the relative intensity increased for the antiparallel β-sheets remarkably having a faster rate increase than the parallel β-sheets.
The reduction of α-helix intensity percentage in favor of the increase of β-sheets are believed to be due to the unfolding of the protein in the presence of ceftrixone as a result of the formation of H bonding between HSA and the antibiotic. The newly formed H-bonding result in the C-N bond assuming partial double bond character due to a flow of electrons from the C=O to the C-N bond which decreases the intensity of the original vibrations (Krimm et al., 1986) ; the hydrogen bonds in α-helix are formed inside the helix and parallel to the helix axis, while for β-sheet, the hydrogen bonds take position in the planes of β-sheets as the preferred orientations especially in the anti-parallel sheets, so the restrictions on the formation of hydrogen bonds in β-sheet relative to the case in α-helix explains the larger effect on reducing the intensity percentage of α-helix to that of β-sheet. Similar conformational transitions from an α-helix to β-sheet structures were observed for the protein unfolding upon protonation and heat denaturation (Surewicz et al., 1987; Holzbaur et al., 1996) . The variation of intensities with temperature change for α-helix, parallel and antiparallel -sheets in ceftriaxone-HSA complexes are shown in Figure 7 . The relative intensity increases as -temperature and ceftriaxone concentration increases-for the antiparallel β-sheets while it remarkably decreases for α-helix and the rate of increase for antiparallel β-sheets remarkably faster than the parallel β-sheets. The difference in behavior for the two types of β-sheets can be explained by the different amino acids and their preferred secondary structural arrangements in these -sheets. It has been reported, that the two forms of -sheets have different thermodynamic propensities scale (Kim et al., 1993) .
The slight gradual increase in intensity of the parallel -sheets is believed to be mainly due to the unfolding of the protein as a result of the formation of H-bonding between HSA and ceftriaxone. The newly formed H-bonding result in the C-N bond assuming partial double bond character due to electrons flow from the C=O to the C-N bond which decreases the intensity of the molecular vibrations (Fabian et al., 1993) .
On the other hand, an increase of intensity implies more stability and less conversions of the C=O bond as a result of the interaction with ceftriaxone. The parallel arrangement is less stable because the geometry of the individual amino acid molecules forces the hydrogen bonds to occur at an angle, making them longer and thus weaker.
Contrarily, in the anti-parallel arrangement, the hydrogen bonds are aligned directly opposite to each other, making stronger and more stable bonds.
Conclusion
The binding of ceftriaxone to HSA has been investigated by fluorescence spectroscopy and by FTIR spectroscopy. the compositions of α-helix to that of the β-sheets. The obtained data show an increase in the intensity of the absorption band of the antiparallel sheets as temperature increases. Higher concentrations of ceftriaxone provide an increase of the absorption band intensity for both the antiparallel and parallel -sheets.
The intensity analysis is in support of higher stability for the anti-parallel -sheets compared to that of parallel β-sheets. These variations in behavior are mainly due to the differences in the intrinsic properties of parallel and antiparallel-β sheets. More experimental studies are needed to determine the degree of stability of β-sheets and how does it affect protein folding.
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